UPC CFI 99/2026

Jan 12, 2026·EP2493466 · NOVEL ANTITUMORAL USE OF CABAZITAXEL

Case details: Status
Case Closed
Action
Other
Category
Other procedural
Parties: Claimants
Zentiva, k.s.Operating co.
Zentiva Pharma GmbHOperating co.
Zentiva FranceOperating co.
Representatives
Anja Lunze
Respondents
Sanofi Mature IPOperating co.
Representatives
Frédéric Chevallier-McDermott Will & Schulte
Division: Munich LD
Judges: Matthias Zigann
Tobias Pichlmaier
Alima Zana
Technology: Chemistry
Pharmaceuticals
Language: English
EPO Opposition: Glenmark Pharmaceuticals Europe Ltd2021-03-10
Accord Healthcare LtdAdmissible2021-03-10
Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
EVER Valinject GmbHWithdrawn2021-03-12
Zentiva k.s.Admissible2021-03-12
medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
Betapharm Arzneimittel GmbHAdmissible2021-03-31
Generics (U.K.) LimitedAdmissible2021-06-08
Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
STADA Arzneimittel AGAdmissible2021-12-09
Maiwald GmbHAdmissible2021-12-10
Accord Healthcare S.L.U.2024-08-30

How this compares

How long the court takes to reach a first decision.

	Median days to first decision
All UPC	124
Munich LD	Locked
Judge Matthias Zigann	Locked
Judge Tobias Pichlmaier	Locked
Judge Alima Zana	Locked

At the UPC: Zentiva Group (15 cases)·Sanofi Group (33 cases)

Related cases

More cases: Munich LD·2026

Documents

Document title	Date	Public
Publication	2026-02-23	Not public
Case closed	2026-02-03	Not public
Receipt	2026-01-12	Not public
Cover sheet	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Exhibit document Applicant	2026-01-12	Not public
Application document Applicant	2026-01-12	Not public